News Merck & Co., Inc.

Equities

MRK

US58933Y1055

Real-time Estimate Cboe BZX Other stock markets 11:43:32 2024-04-26 am EDT			5-day change	1st Jan Change
131.2 ^USD	+0.37%		+4.35%	+20.39%

05:05pm	Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128	MT
04:48pm	Guggenheim Adjusts Price Target on Merck to $146 From $144	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128	11:05am	MT
Guggenheim Adjusts Price Target on Merck to $146 From $144	10:48am	MT
Wells Fargo Adjusts Price Target on Merck & Company to $140 From $135	10:37am	MT
Deutsche Bank Adjusts Price Target on Merck & Company to $140 From $135	10:31am	MT
JPMorgan Chase Adjusts Price Target on Merck to $145 From $140	10:30am	MT
Goldman Sachs Raises Price Target on Merck & Company to $144 From $139	10:13am	MT
Leerink Partners Raises Price Target on Merck & Company to $136 From $132	09:14am	MT
Truist Lifts Price Target on Merck to $143 From $142, Keeps Buy Rating	07:44am	MT
AbbVie raises annual profit forecast on strong Skyrizi sales	07:36am	RE
Jefferies Adjusts Merck & Company Price Target to $150 From $145	07:19am	MT
Cantor Fitzgerald Adjusts Merck & Co.' Price Target to $155 From $135, Keeps Overweight Rating	Apr. 25	MT
Top Midday Stories: Shares of Meta, IBM, Caterpillar, Comcast and Southwest Down Big Post-Earnings; AstraZeneca Shares See Post-Earnings Bump	Apr. 25	MT
Global markets live: Ford, Dow, American Airlines, Comcast, Apple, IBM, Cisco...	Apr. 25
The specter of stagflation rears its ugly head again	Apr. 25
Transcript : Merck & Co., Inc., Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Merck Lifts Full-Year 2024 Outlook Following First-Quarter Beat	Apr. 25	MT
Merck raises annual target ranges	Apr. 25	CF
Merck Non-GAAP Earnings, Sales Rise; 2024 Guidance Raised	Apr. 25	MT
(MRK) MERCK & CO. Expects Fiscal Year 2024 EPS Range $8.53 - $8.65	Apr. 25	MT
Earnings Flash (MRK) MERCK & CO. Reports Q1 Revenue $15.78B	Apr. 25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Merck & Co., Inc.

Equities

MRK

US58933Y1055

Summary

Filters